3 ms·
> Moral hazard: an improved vaccine will reduce future business (more booster shots). There is absolutely no incentive for big pharma to make better vaccines.
by mariuolo 5y ago
> Moral hazard: an improved vaccine will reduce future business (more booster shots). There is absolutely no incentive for big pharma to make better vaccines.
You assume the pharmaceutical industry always acts like a cartel and its members aren't in competition with each other: if one of them created a more long-lasting vaccine, it would capture a larger share of the market.
There's your incentive.
- Arnt 5y agoAnd indeer, Curevac (the mRNA startup that lost against Biontech and Moderna) has published this: https://www.curevac.com/en/2021/10/12/curevac-to-shift-focus-of-covid-19-vaccine-development-to-second-generation-mrna-technology/ https://www.curevac.com/en/2021/10/12/curevac-to-shift-focus... All three of those companies know that the two with the best vaccines made billions, the third made a loss.